Edgewise Therapeutics Inc

Research Edgewise Therapeutics Inc (EWTX) on Bullrun: market cap USD 4.40B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerEWTX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 4.40B
• Financial periodFY2025
• Net income-USD 167.80K
• Free cash flow-USD 144.07M

Valuation Snapshot

latest market cap is USD 4.40B.

About Edgewise Therapeutics Inc

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, sevasemten, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy.

Frequently asked questions

What is Edgewise Therapeutics Inc's market cap?

Edgewise Therapeutics Inc's market capitalization is USD 4.40B.

What does Edgewise Therapeutics Inc do?

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.